Topic description and stories

GLP-1 Agonists are injectable drugs that regulate blood sugar levels and have also been shown to promote weight loss, making them an attractive form of treatment for Type 2 diabetes, which is often linked to obesity.

Study highlights possible knowledge gap over effects of some diabetes drugs

18 Sep 2015

Scientists have found that some drugs from a group of anti-diabetic treatments may, in certain circumstances, act on glucagon receptors in the body...

Read more
Naked Mole-rat

Naked Mole-Rats: are these rodents immune to cancer?

02 Sep 2015

The Cambridge Animal Alphabet series celebrates Cambridge's connections with animals through literature, art, science and society. Here, N is for...

Read more
Impatiently Waiting

Cancer patients lose faith in healthcare system if referred late by GP

31 Jul 2015

If it takes more than three trips to the GP to be referred for cancer tests, patients are more likely to be dissatisfied with their overall care...

Read more

Lung model

Hope for first treatment targeting cause of debilitating heart and lung disease

17 Jun 2015

A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of pulmonary arterial...

Read more
Mines

Immorality and invention: the “great stem cell debate”

28 Oct 2014

Human stem cell research holds promise for combating some of the most recalcitrant of diseases and for regenerating damaged bodies. It is also an...

Read more
DNA code

Novel genetic mutations cause low metabolic rate and obesity

25 Oct 2013

Researchers believe the gene could be a useful therapeutic target for treating obesity and type 2 diabetes

Read more

Phone

Therapy over the phone as effective as face-to-face

28 Sep 2012

Phone therapy also increases access and potentially decreases costs.

Read more
Partial view of genetic analysis

Landmark breast cancer study paves way for tailored treatments

18 Apr 2012

Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.

Read more
Molecular sacs of debris (pink) are delivered to the lysosome (dark red)

Autophagy: when ‘self-eating’ is good for you

03 Apr 2012

New discoveries by Cambridge scientists about a molecular waste-disposal process that ‘eats’ bacteria are influencing the clinical management of...

Read more

Lighthouse

Beacons of life and death: chromatin and cancer

01 Jan 2010

A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.

Read more
Waldmann, Clark and Hale

Campath: from innovation to impact

01 Aug 2009

The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to...

Read more
Drying

Drying without dying

01 May 2009

Some remarkable organisms are able to withstand almost complete desiccation. How they survive is providing Cambridge researchers with new ideas for...

Read more

Pages